Risk assessment and risk stratification in sudden cardiac death: A biostatistician's view

PACE - Pacing and Clinical Electrophysiology

Volumn 20, Issue 10 II, 1997, Pages 2520-2532

  Church, Timothy R ^a,b  

^a UNIVERSITY OF MINNESOTA   (United States)

^b Box 807 Mayo   (United States)

Author keywords

Risk assessment; Risk stratification; Sudden cardiac death

Indexed keywords

ARTIFICIAL NEURAL NETWORK; CONFERENCE PAPER; HEART ARRHYTHMIA; MULTIVARIATE ANALYSIS; PROBABILITY; RANDOMIZATION; RISK ASSESSMENT; STATISTICAL ANALYSIS; STATISTICAL MODEL; STATISTICS; SUDDEN DEATH;

ARRHYTHMIA; BIAS (EPIDEMIOLOGY); DATA INTERPRETATION, STATISTICAL; DEATH, SUDDEN, CARDIAC; HUMANS; NEURAL NETWORKS (COMPUTER); PROSPECTIVE STUDIES; RANDOMIZED CONTROLLED TRIALS; REGRESSION ANALYSIS; RISK ASSESSMENT; RISK FACTORS;

EID: 0030669462     PISSN: 01478389     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1540-8159.1997.tb06101.x     Document Type: Review

References (53)

1. Hallstrom AP, Cobb LA, Yu BH. Influence of comorbidity on the outcome of patients treated for out-of hospital ventricular fibrillation. Circulation 1996; 93:2019-2022.
2. Ortiz J, Ghefter CGM, Silva CES, et al. One-year mortality prognosis in heart failure: A neural network approach based on echocardiographic data. J Am Coll Cardiol 1995; 26:1586-1593.
3. Gomez-Marin O, Folsom AR, Kottke TE, et al. Improvement in long-term survival among patients hospitalized after acute myocardial infarction, 1970 to 1980: The Minnesota Heart Survey. N Engl J Med 1987; 316:1353-1359.
4. Demirovic J, Myerburg R. Epidemiology of sudden cardiac death: An overview. Prog Cardiovasc Dis 1994; 37:39-48.
5. Morrison AS. Screening in Chronic Disease. New York, NY, Oxford University Press, 1985, pp. 42-47.
6. Lusted L. Introduction to Medical Decision Making. Springfield, IL, CC Thomas, 1968.
7. Henderson M. Validity of screening. Cancer 1976; 37:573-581.
8. Greenberg ER, Baron JA, Dain BJ, et al. Cancer staging may have different meanings in academic and community hospitals. J Clin Epidemiol 1991; 44:505-512.
9. Kennedy HL, Caralis DG. Ambulatory electrocardiography: A clinical perspective. Ann Intern Med 1977; 87:729-739.
10. Bigger JT, Fleiss JL, Kleiger R, et al. The relationships among ventricular arrhythmias, left ventricular dysfunction, and mortality in the 2 years after myocardial infarction. Circulation 1984; 69:250-258.
11. Copie X, Hnatkova K, Staunton A, et al. Spectral turbulence vs. time-domain analysis of signal-averaged ECG used for the prediction of different arrhythmic events in survivors of acute myocardial infarction. J Cardiovasc Electrophysiol 1996; 7:583-593.
12. Moore EN. Mechanisms and models to predict a QTc effect. Am J Cardiol 1993; 72:4B-9B.
13. Barron HV, Lesh MD. Autonomic nervous system and sudden cardiac death. J Am Coll Cardiol 1996; 27:1053-1060.
14. Huikuri HV, Seppänen T, Koistinen MJ, et al. Abnormalities in beat-to-beat dynamics of heart rate before the spontaneous onset of life-threatening ventricular tachyarrhythmias in patients with prior myocardial infarctions. Circulation 1996; 93:1836-1844.
15. Wilber DJ, Garan H, Finkelstein D, et al. Out-of-hospital cardiac arrest. Use of electrophysiologic testing in the prediction of long-term outcome. N Engl J Med 1988; 318:19-24.
16. Skale BT, Miles WM, Heger JJ, et al. Survivors of cardiac arrest: Prevention of recurrence by drug therapy as predicted by electrophysiologic testing or electrocardiographic monitoring. Am J Cardiol 1986; 57:113-119.
17. Brachmann J, Karolyi L, Seidl K-H, et al. Analysis of RR intervals prior to spontaneous ventricular fibrillation in patients with a new implantable cardioverter-defibrillator. (abstract) PACE 1996; 19:566.
18. Mahmud R, Denker ST, Tchou PJ, et al. Modulation of conduction and refractoriness in atrioventricular junctional reentrant circuit. Effect on reentry initiated by atrial extrastimulus. J Clin Invest 1988; 81:39-46.
19. The Multiple Risk Factor Intervention Trial Group. Statistical design considerations in the NHLI Multiple Risk Factor Intervention Trial (MR-FIT). J Chron Dis 1977; 30:261-275.
20. Mueller WH, Kaplowitz HJ. The precision of anthropometric assessment of body fat distribution in children. Ann Human Biol 1994; 21:267-274.
21. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Heart rate variability: Standards of measurement, physiological interpretation, and clinical use. Circulation 1996; 93:1043-1065.
22. Pratt CM, Greenway PS, Schoenfeld MH, et al. Exploration of the precision of classifying sudden cardiac death: Implications for the interpretation of clinical trials. Circulation 1996; 93:519-524.
23. Campbell NR, McKay DW, Chockalingham A, et al. Errors in assessment of blood pressure: Blood pressure measuring technique. Can J Public Health 1994; 85(Suppl.):S18-S21.
24. Swerdlow CD, Chen P-S, Kass RM, et al. Discrimination of ventricular tachycardia from sinus tachycardia and atrial fibrillation in a tiered-therapy cardioverter-defibrillator. J Am Coll Cardiol 1994; 23:1342-1355.
25. Epstein AE, Carlson MD, Fogoros RN, et al. Classification of death in antiarrhythmia trials. J Am Coll Cardiol 1996; 27:433-442.
26. Simon SR, Powell LH, Bartzokis TC, et al. A new system for classification of cardiac death as arrhythmic, ischemic, or due to myocardial pump failure. Am J Cardiol 1995; 76:896-898.
27. Ector H, Rogers R, Rubens A, et al. Classification of death in patients under antiarrhythmic treatment. PACE 1993; 16:2250-2254.
28. Greene HL, Richardson DW, Barker AH, et al. Classification of deaths after myocardial infarction as arrhythmic or nonarrhythmic (the Cardiac Arrhythmia Pilot Study). Am J Cardiol 1989; 63:1-6.
29. Neuwirth RB. Considerations in the Estimation of the Event Rate in the Control Group for Intervention Trials. Plan B Paper, Division of Biostatistics, University of Minnesota, 1990.
30. Church T, Ederer F, Mandel J, et al. Estimating the duration of ongoing prevention trials. Am J Epidemiol 1993; 137:797-810.
31. Cairns J, Cohen L, Colton T, et al. Issues in the early termination of the aspirin component of the Physicians' Health Study. Ann Epidemiol 1991; 1:395-405.
32. Wilhelmsen L, Ljungberg S, Wedel H, et al. A comparison between participants and non-participants in a primary prevention trial. J Chron Dis 1976; 29:331-339.
33. Ederer F, Church T, Mandel J. Sample sizes of prevention trials have been too small. Am J Epidemiol 1993; 137:787-796.
34. Hughes MD, Pocock SJ. Within-subject diastolic blood pressure variability: Implications for risk assessment and screening. J Clin Epidemiol 1992; 45:985-998.
35. Lachenbruch P. Discriminant Analysis. New York, NY, Hafner Press, 1975, p. 30.
36. Laud PW, Ibrahim JG. Predictive specification of prior model probabilities in variable selection. Biometrika 1996; 83:267-274.
37. Ahnve S. Correction of QT interval for heart rate: Review of different formulas and the use of Bazett's formula in myocardial infarction. Am Heart J 1985;109:568-574.
38. Porebski OR. On the interrelated nature of the multivariate statistics used in discriminatory analysis. Br J Math Stat Psychol 1966; 19:197-214.
39. Hosmer DW, Lemeshow S. Applied Regression Analysis. New York, NY, John Wiley & Sons, 1989.
40. Efron B. The efficiency of logistic regression compared to normal discriminant analysis. J Am Stat Assoc 1975; 70:892-898.
41. Press SJ, Wilson S. Choosing between logistic regression and discriminant analysis. J Am Stat Assoc 1978; 73:699-705.
42. SAS/STAT, User's Guide, Version 6, 4th ed, Vol 2, SAS Institute, Cary, NC, 1990.
43. Cox DR. Regression models and life tables. J Royal Stat Soc Ser B 1972; 34:187-202.
44. El-Sherif N, Denes P, Katz R, et al. Definition of the best prediction criteria of the time domain signal-averaged electrocardiogram for serious arrhythmic events in the postinfarction period. J Am Coll Cardiol 1995; 25:908-914.
45. Breiman L, Friedman JH, Olshen RA, et al. Classification and Regression Trees. Belmont, CA, Wadsworth, 1984.
46. Gordon L, Olshen RA. Tree-structured survival analysis. Cancer Treatment Reports 1985; 69:1065-1068.
47. Segal MR. Regression trees for censored data. Biometrics 1996; 44:35-47.
48. Segal MR, Bloch DA. A comparison of estimated proportional hazard models and regression trees. Stat Med 1989; 8:539-550.
49. Warner B, Misra M. Understanding neural networks as statistical tools. Am Statistician 1996; 50:284-293.
50. Tu JV. Advantages and disadvantages of using artificial neural networks versus logistic regression for predicting medical outcomes. J Clin Epidemiol 1996; 49:1225-1231.
51. Makuch RW, Simon RM. Sample size requirements for comparing time-to-failure among k treatment groups. J Chron Dis 1982; 35:861-867.
52. Wu M, Fisher M, DeMets D. Sample sizes for long-term medical trials with time-dependent dropout and event rates. Controlled Clin Trials 1980; 1:109-121
53. Coste J, Bouyer J, Job-Spira N. Construction of composite scales for risk assessment in epidemiology: An application to ectopic pregnancy. Am J Epidemiol 1997; 145:278-289.